SRZNW

Conviction 27HealthcareScan · Mon, Aug 10, 2026

SRZNW$0.0015-60.53%

ResistanceSupportVol 14

Vol MA14 7.44K

May 8May 27Jun 15Jul 2Jul 22Aug 7

Surrozen, Inc./DEBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.surrozen.com ↗

Price0.0015

Change-60.53%

Gap-60.53%

Rel volume2.25×

Avg volume12.83K

Avg $ vol86.79

SMA 200.0046

SMA 500.0069

SMA 2000.0096

Price vs 50-78.20%

Price vs 200-84.37%

MA stackbearish

50/200 cross—

Supertrenddown · 0.0181

RSI (14)48

MACD hist-0.00

MACD crossbear · 4d

Stoch %K / %D10 / 25

ADX (14)9

+DI / −DI42 / 37

RSI divergence—

MACD divergence—

ATR %+413.86%

ADR %35.19%

52w high0.0274

52w low0.0000

From 52w high-94.53%

Above 52w low—

New 52w highNo

SqueezeOff

Bollinger width496.29%

%B0.36

Donchian pos9.49%

Donchian high0.0158

Donchian low0.0000

AVWAP (52w high)0.0911

vs AVWAP high-98.35%

AVWAP (52w low)0.0705

vs AVWAP low-97.87%

OBV trendDown

Chaikin MF (20)-0.30

Today vs 20d2.25×

Avg vol (14d)7.44K

Avg vol (20d)12.83K

Avg $ vol (20d)86.79

Market cap17.63K

RS 3m (vs SPY)—

RS 6m (vs SPY)—

RS line new highNo

Trend template0/7

Technical rank2.7

1 week—

1 month-84.85%

3 months—

6 months—

1 year-90.32%

YTD—

P/E-0.00

P/B-0.00

P/S0.01

P/FCF-0.00

EPS-32.37

Div yield—

ROE110.68%

ROA-209.35%

Debt/Eq—

Current12.14

EV/EBITDA2.46

Gross margin—

Net margin—

Rev growth-67.37%

EPS growth-280.76%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value-102.02M

Revenue5M

Net income50.18M

Gross profit—

Free cash flow-30.37M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out3.21M

Employees44

ListedThu, Aug 12, 2021

Free float11.75M

Float %100.0%

Short interest10.05K

Days to cover0.6d

Short volume—

Squeeze score23 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction27 / 100

Pattern quality—

Tech rank2.7 / 100

Group rank—

Status laneNo active setup

Setup direction—

Pattern family

Resistance0.0166

Support0.0000

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in SRZNW

All disclosures →

No recent disclosed trades by Congress in SRZNW. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in SRZNW

No recent insider (Form 4) filings in SRZNW. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in SRZNW

EDGAR →

No recent SEC filings on file for SRZNW.

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.